About the Authors:
Simon Lindhoud
Contributed equally to this work with: Simon Lindhoud, Willy A. M. van den Berg
Affiliation: Laboratory of Biochemistry, Wageningen University, Wageningen, The Netherlands
Willy A. M. van den Berg
Contributed equally to this work with: Simon Lindhoud, Willy A. M. van den Berg
Affiliation: Laboratory of Biochemistry, Wageningen University, Wageningen, The Netherlands
Robert H. H. van den Heuvel
Current address: MSD, Oss, The Netherlands
Affiliation: Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Albert J. R. Heck
Affiliation: Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Carlo P. M. van Mierlo
Affiliation: Laboratory of Biochemistry, Wageningen University, Wageningen, The Netherlands
Willem J. H. van Berkel
* E-mail: [email protected]
Affiliation: Laboratory of Biochemistry, Wageningen University, Wageningen, The Netherlands
Introduction
Proteins are sensitive to oxidative damage and the resulting protein modifications often have considerable biological effects. For example, protein oxidation has been suggested as a causative or contributory factor in many diseases [1]. Furthermore, oxidized proteins have been found to increase in aged organisms, suggesting that protein oxidation contributes to aging [2], [3]. Of particular interest is oxidation of methionine and cysteine residues, because this conversion happens for a wide variety of proteins and often affects their biological activity [4], [5].
Oxidation of methionine to its sulfoxide state can be stimulated by biological oxidants such as H2O2, but also by environmental oxidants like ozone [6]. Methionine oxidation can be (partially) reversed by the action of methionine sulfoxide reductases [7]. Such repair of oxidative damage suggests a potential for in vivo regulation of protein function by reversible methionine oxidation [8], [9], [10], [11].
The most oxidation sensitive and reactive amino-acid residue is cysteine. The presence of reactive cysteine residues is indicative of functionality, and affects many biochemical processes [12]. Oxidation of protein thiols involves consecutive formation of sulfenic, sulfinic and sulfonic acids [13], as shown in Figure 1. Sulfenic acids are intermediates during formation of disulfide bonds [14], but have also been recognized as naturally occurring states of cysteinyl residues critical to catalytic and regulatory processes [15], [16]. Recent evidence suggests that protein sulfenic acids are widespread posttranslational oxidative modifications in healthy mammalian tissues, and that their presence increases in response to elevated concentrations of H2O2 [17], [18], [19], [20], [21].
[Figure omitted. See PDF.]
Figure 1. Oxidation states of protein cysteines, and their reversibility by DTT.
Schematic diagram showing steps involved in hydrogen peroxide-induced oxidation and DTT-induced reduction of protein cysteines.
https://doi.org/10.1371/journal.pone.0041363.g001
When protective mechanisms fail, protein thiols may be further oxidized to the sulfinic acid state or the irreversible sulfonic acid state [22], [23]. Consequently, protein sulfinylation and sulfonylation has been linked to cell aging and cell death [24]. Aging has been investigated for several purified proteins. For example, in case of p-hydroxybenzoate hydroxylase from Pseudomonas fluorescens, oxidative aging produces sulfonic acid derivatives of Cys116 [22]. Substitution of this cysteine by a serine precludes oxidation and prevents protein aggregation [25]. In case of Trigonopsis variabilis D-amino acid oxidase, stress-induced oxidation results in decreased protein stability due to the irreversible formation of the sulfinic acid state of Cys108 [26]. However, in case of peroxidoredoxin, the sulfinic acid state of the active site cysteine can be rapidly transformed into the catalytically active thiol state [27]. This reduction probably requires specific enzymes. In contrast, matrix metalloproteinase-7 is activated by oxidation of Cys70 into sulfinic acid [28].
In this study, we report the sensitivity towards oxidative damage of a 179-residue flavodoxin from A. vinelandii. The protein functions as an FMN-dependent one-electron transporter to nitrogenase in the nitrogen fixation pathway of this bacterium [29]. Flavodoxin adopts the α–β parallel topology [30], also referred to as the doubly-wound or flavodoxin-like topology, which is one of the most common folds observed. Flavodoxins are the structurally most investigated flavoproteins and have emerged as prototypes for the investigation of protein folding [31], [32], [33], [34], [35], [36], [37]. Furthermore, flavodoxins are found in many prokaryotes, but also as protein domains in eukaryotes (e.g., in nitric oxide synthase) [38].
A. vinelandii flavodoxin contains two residues that are potentially sensitive to oxidation: a methionine at position 30 and a cysteine at position 69. Whereas the side chain of the methionine is hidden in the protein interior, the cysteine is located in a loop at the surface and in immediate vicinity of the FMN cofactor (Figure 2), as is the case for many other flavodoxins. NMR studies on the nearly identical flavodoxin from Azotobacter chroococcum show that this loop is involved in intermolecular interactions with the nitrogenase enzyme system [39]. Indeed, biological activity is lost upon covalent dimerization of A. vinelandii flavodoxin molecules through formation of an intermolecular disulfide bridge. [40], [41], [42]. Currently, the exact physiological role of Cys69 is unclear. It is suggested to function as an additional redox active centre to FMN, or to be involved in an activation/deactivation mechanism of the protein [43].
[Figure omitted. See PDF.]
Figure 2. Cartoon drawing of the X-ray structure of flavodoxin from A. vinelandii.
α-Helices are shown in red, β-strands in blue and loops in white. The FMN cofactor is coloured yellow and the backbone of residue 69 is coloured magenta. Note that this residue is in immediate vicinity of FMN. The X-ray structure is of the C69A variant of the protein (pdb ID 1YOB) [30], in which the single cysteine at position 69 is replaced by alanine. This protein variant is largely similar to flavodoxin regarding both redox potential of holoprotein and stability of apoprotein [42], [54].
https://doi.org/10.1371/journal.pone.0041363.g002
Upon removal of the non-covalently bound flavin from flavodoxin, apoflavodoxin is generated. NMR data show that apoflavodoxin strongly resembles flavodoxin, except for dynamic disorder in the flavin-binding region [44]. Due to this flexibility, disulfide-linked dimerization of apoflavodoxin happens more rapidly than is the case for flavodoxin [40]. Here, we use H2O2 to induce oxidative stress on flavodoxin as well as apoflavodoxin. We address the effects of oxidative stress through analysis of the various protein modifications formed, and highlight the importance of the cofactor in protecting flavoproteins against irreversible oxidation and potentially other covalent thiol modifications.
Results
Cys69 of (apo)flavodoxin is sensitive to oxidation
MonoQ anion exchange chromatography of freshly purified flavodoxin shows the presence of two protein species, eluting at 470 and 510 mM KCl, respectively (Figure 3a). Depending on protein preparation, the first eluting species amounts to about 50–70% of total protein. Incubation of flavodoxin with 10 mM DTT for a period of 10 min causes complete conversion of the second into the first eluting species (Figure 3b). This observation shows that Cys69 is reversibly modified in the second eluting species. Preparations of Cys69Ala (C69A) flavodoxin elute as a single species during anion exchange chromatography.
[Figure omitted. See PDF.]
Figure 3. MonoQ anion exchange chromatography elution profiles of flavodoxin and apoflavodoxin.
(A) Flavodoxin (40 μM). (B) Flavodoxin (40 μM), kept in the presence of 10 mM DTT for a period of 10 min. (C) Apoflavodoxin (50 μM). (D) Apoflavodoxin (50 μM), kept in the presence of 10 mM DTT for a period of 10 min. Gradient composition: buffer A is 25 mM Tris-HCl pH 8.0, and buffer B is 25 mM Tris-HCl pH 8.0, containing 1 M KCl. Flow rate is 1.0 mL/min. Dashed lines show conductivities of elution buffers. The molecule eluting at 7 mL is DTT. Temperature is 25°C.
https://doi.org/10.1371/journal.pone.0041363.g003
During size-exclusion chromatography, flavodoxin elutes almost exclusively as monomer. Thus, the second flavodoxin species detected by anion exchange chromatography is not disulfide linked protein dimer, but instead involves another thiol modification. We propose that the species eluting at 510 mM KCl at pH 8 (Figure 3a), is protein with Cys69 in the sulfenic acid state (Figure 1), because it is converted into protein that elutes at 470 mM KCl after incubation with DTT (Figure 3b). This DTT-induced conversion is not expected to happen when flavodoxin's thiol would be oxidised to the sulfinic or sulfonic acid state [22], [23], [45]. In addition, because the pKa of sulfenic acid is about 5.9 [16], at pH 8 one expects retarded elution on an anion exchange column of the sulfenic acid state of flavodoxin compared to non-oxidised protein, just as we observe (Figure 3a).
In case of apoflavodoxin, MonoQ anion exchange chromatography reveals two major protein species, eluting at 420 and 460 mM KCl, respectively (Figure 3c). The fraction of the second species increases proportional to the time during which apoprotein stock is left in absence of DTT. Subsequent incubation of apoflavodoxin with 10 mM DTT causes almost complete conversion of this second species into the first eluting one (Figure 3d). Thus, Cys69 is reversibly modified in the second eluting species. Size-exclusion chromatography shows that freshly prepared apoflavodoxin is predominantly monomeric but slowly dimerizes during storage (data not shown). Apoflavodoxin dimers elute at 460 mM KCl in MonoQ anion exchange chromatography. These dimers are disulfide-linked, because upon incubation with excess DTT, they convert into monomeric species.
Reactivity with DTNB and NBD-Cl
Incubation of apoflavodoxin (stored in presence of DTT prior to experiments, to avoid protein dimerization) as well as of flavodoxin with DTNB leads to formation of nearly stoichiometric amounts of TNB. In case of flavodoxin, protein modification proceeds rather slowly and takes about 30 min to complete, whereas apoflavodoxin is modified within 2 min (for experimental circumstances see Materials and Methods). The observed difference in reactivity shows that Cys69 is better accessible to Ellman's reagent in apoprotein than in holoprotein, consistent with the observation that the flavin-binding region of apoflavodoxin (and thus of the loop in which Cys69 resides) is flexible, whereas this region is rigid in flavodoxin [44]. To explain stoichiometric formation of TNB in case of flavodoxin, holoprotein with Cys69 in the sulfenic acid state must react with DTNB. Indeed, reactivity of sulfenic acids with TNB has been reported [46].
Flavodoxin does not react appreciably with NBD-Cl, whereas the reaction of this reagent with freshly prepared, DTT-pre-treated, apoflavodoxin takes 60 min to complete. The absorption maximum at 420 nm of the apoflavodoxin adduct formed (Figure 4) is characteristic for thioether linked NBD (Figure 5) [47]. Hence, Cys69 of apoflavodoxin stock is in the thiol state. No sulfoxide adduct is detected, because (i) apoflavodoxin preparation involves TCA precipitation of holoprotein and at the resulting low pH sulfenic acid is unstable [15], and (ii) apoflavodoxin is stored in presence of 10 mM DTT prior to NBD-Cl treatment, causing sulfenic acid to transform into thiol.
[Figure omitted. See PDF.]
Figure 4. Spectroscopic characteristics of apoflavodoxin modified with NBD.
Apoprotein (20 μM) before (solid line) and after (dashed line) incubation with 200 μM NBD-Cl for 1 hour. Modified protein absorbs maximally at 420 nm, which is characteristic for the presence of a thiol-NBD conjugate [47].
https://doi.org/10.1371/journal.pone.0041363.g004
[Figure omitted. See PDF.]
Figure 5. Reactions of NBD-Cl with protein cysteine and sulfenic acid states.
Schematic diagram showing steps involved in reaction of NBD-Cl with cysteine and sulfenic acid.
https://doi.org/10.1371/journal.pone.0041363.g005
Native MS and LC-MS analysis
By using native mass spectrometry [48] we detect flavodoxin, which has an MS spectrum that shows a narrow charge state distribution (i.e., +7 to +9) (Figure 6). The corresponding molecular mass equals (19995±3) Da, which closely agrees with the expected mass of the holoprotein with cysteine in the thiol state (Table 1). Freshly prepared, DTT-pre-treated, native apoflavodoxin exhibits a similar narrow distribution of charge states (i.e., +7 to +9), and the corresponding molecular mass is (19538±3) Da (Table 1). The mass difference between holo- and apoprotein establishes that flavodoxin indeed contains a single, non-covalently bound, FMN cofactor.
[Figure omitted. See PDF.]
Figure 6. LC-MS and native MS spectra of flavodoxin.
(A) LC-MS spectrum of flavodoxin. (B) Nano-electrospray mass spectrum of flavodoxin. MH+n represents flavodoxin monomer with n positive charges, and M+n is apoflavodoxin monomer with n positive charges. (C and D) Spectra of area indicated by the grey contour in (A) and (B), respectively. Flavodoxin (5 µM) is in 50 mM ammonium acetate, 0.1 mM EDTA, pH 6.8.
https://doi.org/10.1371/journal.pone.0041363.g006
[Figure omitted. See PDF.]
Table 1. Native mass spectrometry of (apo)flavodoxin.
https://doi.org/10.1371/journal.pone.0041363.t001
During LC-MS analysis, we first inject flavodoxin into the LC part of the set-up and subsequently electrospray it into a mass spectrometer. In the reverse-phase chromatography step, which involves use of acetonitrile and TFA, flavodoxin loses FMN and subsequently apoprotein unfolds. As a consequence of this unfolding, the corresponding LC-MS spectrum displays a broad distribution of charged protein molecules (i.e., +7 to +17) (Figure 6), clearly distinct from the native MS data. Again due to unfolding, the LC-MS spectrum of apoflavodoxin is identical to the one of holoprotein. Unfolded apo- and holoprotein both are observed with a molecular mass of (19533±1.5) Da, which agrees very well with their predicted masses (i.e., 19531.8 Da; Table 2), assuming that cysteine is in the thiol state and the co-factor has been released from the holoprotein. In case of holo- as well as apoprotein we observe no sulfenic acid, because acetonitrile-TFA usage during the reversed phase chromatography step of LC-MS and resulting low pH causes instability of sulfenic acid [15].
[Figure omitted. See PDF.]
Table 2. LC-MS analysis of (apo)flavodoxin.
https://doi.org/10.1371/journal.pone.0041363.t002
The above observations show that flavodoxin and apoflavodoxin are sensitive to thiol oxidation, prompting further investigation of this phenomenon.
Hydrogen peroxide-mediated oxidation of apoflavodoxin
To prevent intermolecular disulfide bond formation in apoflavodoxin, protein is stored in presence of 10 mM DTT. Just before incubation with H2O2, this reducing agent is removed to avoid interferences with H2O2. Size-exclusion chromatography shows that freshly prepared apoflavodoxin is predominantly monomeric (Figure 7A). Upon incubation of apoflavodoxin with 10 mM H2O2 the relative amount of protein dimers strongly increases (Figure 7B). In contrast, upon incubation of C69A apoflavodoxin with H2O2 no protein dimerization takes place (Figure 7C–D).
[Figure omitted. See PDF.]
Figure 7. Superdex 75 size exclusion chromatography elution profiles of apoflavodoxin.
(A) Apoflavodoxin (38 μM). (B) Apoflavodoxin (38 μM) after 22 h incubation with 10 mM H2O2 at 4°C. (C) C69A apoflavodoxin (79 μM). (D) C69A apoflavodoxin (79 μM) after 24 h incubation with 10 mM H2O2 at 4°C. Flow rate is 0.5 mL/min and temperature is 25°C.
https://doi.org/10.1371/journal.pone.0041363.g007
We used LC-MS to follow H2O2-induced oxidation of apoflavodoxin at room temperature. Figure 8a shows the LC-MS spectrum of apoprotein prior to its incubation with H2O2. Clearly, only monomeric, non-oxidised, apoflavodoxin is detected. After incubating apoflavodoxin with 10 mM H2O2 for 30 min, the corresponding LC-MS spectrum shows appearance of signal of protein dimer (measured mass (39066±5) Da) (Figure 8B). The population of dimer rises upon increasing incubation time. Again, this dimer is disulfide-linked, because upon incubation with 10 mM DTT it converts into monomeric species. Besides a tiny population of protein in sulfinic acid state (labelled MO2 in Fig 6b), no other oxidation products of monomeric apoflavodoxin are detected, even when incubation with H2O2 lasts up to two hours. Thus, under the conditions applied, Met30 of apoflavodoxin is not susceptible to peroxide-mediated sulfoxidation.
[Figure omitted. See PDF.]
Figure 8. Monitoring of (apo)flavodoxin under H2O2-induced oxidative stress by LC-MS.
For clarity, the zoomed in LC-MS regions that display the +10 charge state of monomer and the +19 charge state of dimer are shown (i.e., m/z range of 1940 to 2070); however, analysis is done on the whole m/z range. (A) Apoflavodoxin. (B) Apoflavodoxin incubated for 30 min with 10 mM H2O2. (C) Apoflavodoxin incubated for 30 min with 100 mM H2O2. (D) Apoflavodoxin incubated for 30 min with 200 µM NBD-Cl and 100 mM H2O2. (E) Flavodoxin incubated for 30 min with 190 µM NBD-Cl and 100 mM H2O2. Protein concentration is 5 µM and incubations were done at room temperature. M represents apoflavodoxin monomer with non-oxidised thiol; MO, MO2 and MO3 are the sulfenic, sulfinic and sulfonic acid states of apoflavodoxin, respectively. M-NBD is monomer protein with the thiol adduct of NBD-Cl, MO-NBD is monomer protein with the sulfenic acid adduct of NBD-Cl, and D represents disulfide-linked apoflavodoxin dimer.
https://doi.org/10.1371/journal.pone.0041363.g008
Incubation of apoflavodoxin with 100 mM H2O2 for a period of 30 min leads to detection of four protein species by LC-MS (Figure 8C). These species are: non-oxidised protein monomer (M), protein dimer, and protein monomer in sulfinic or sulfonic acid state (labelled MO2 and MO3, respectively). Upon incubation with DTT, only the apoflavodoxin dimer disappears from the LC-MS spectrum, showing that oxidation of Cys69 to its sulfinic or sulfonic acid state is irreversible with respect to this reducing agent. No ion intensity at the expected mass of the sulfenic acid state of apoflavodoxin is observed (Figure 8C). Again, usage of acetonitrile and TFA during the reversed phase chromatography step destabilizes sulfenic acid, preventing its detection by LC-MS. Upon increasing the H2O2-incubation period, dimer intensity in LC-MS spectra no further raises. The latter phenomenon is in line with Figure 1, which shows the proposed mechanism for apoflavodoxin oxidation. The most likely first event during H2O2 treatment is formation of sulfenic acid [16]. Subsequently, this intermediate either reacts rapidly with Cys69 of another apoflavodoxin monomer to form protein dimer or oxidises further under influence of H2O2 to sulfinic and sulfonic acid states of apoflavodoxin. Upon increasing the time of incubation with 100 mM H2O2 beyond 30 min, competition between both processes depletes sulfenic acid intermediate and hence no increase in relative population of apoflavodoxin dimer is detected.
Trapping of sulfenic acid state during apoflavodoxin oxidation
To support actual formation of a sulfenic acid intermediate during oxidation of apoflavodoxin, H2O2-mediated oxidation of apoprotein was studied in presence of NBD-Cl. This procedure enables spectroscopic and mass discrimination between NBD adducts of thiols and sulfenic acids [46], [47], [49]. Now, a 30 min incubation at room temperature gives rise to formation of only a minor population of protein dimers (Figure 8D) that does not increase upon prolonged incubation. Besides dimer, LC-MS detects five additional monomeric apoflavodoxin species, including protein non-oxidised thiol (M) and protein in sulfinic (MO2) or sulfonic (MO3) acid state. In addition, protein with the thiol adduct of NBD-Cl (labelled M-NBD) and with the sulfenic acid adduct of NBD-Cl (labelled MO-NBD) are identified (Figure 4). This observation shows that the sulfenic acid intermediate can be trapped by NBD-Cl and indeed forms during H2O2-induced oxidation of apoflavodoxin.
Hydrogen peroxide-mediated oxidation of flavodoxin
In contrast to apoflavodoxin, incubation of flavodoxin for a 30 min period with 100 mM H2O2 and 190 µM NBD-Cl does not cause formation of protein dimer, nor of protein species MO2, MO3, M-NBD and MO-NBD, as LC-MS reveals (Figure 8E). Clearly, flavodoxin is much better protected against formation of these products than apoflavodoxin. In addition, like in apoflavodoxin, Met30 of flavodoxin is not susceptible to peroxide-mediated sulfoxidation.
Does H2O2-mediated oxidation of flavodoxin cause production of holoprotein with Cys69 in the sulfenic acid state? Whereas the LC-MS methodology prevents detection of protein with sulfenic acid, due to usage of acetonitrile-TFA during reversed phase chromatography, MonoQ anion exchange chromatography can detect such species, as discussed (Figure 3A, B). Using the latter methodology, we indeed observe that upon incubation of flavodoxin with 10 mM H2O2 for a period of 30 min at room temperature, approximately 85% of protein is in the sulfenic acid state (i.e., elutes at 510 mM KCl, data not shown). However, in holoprotein, neither subsequent further oxidation to sulfinic and sulfonic acid nor formation of intermolecular disulfides is observed (Figure 8).
Discussion
Cofactor binding protects flavodoxin against oxidative stress
Many proteins require binding of a cofactor to be functional. However, the role of such ligands in protein oxidation and stability is scarcely addressed [50]. Binding of cofactors stabilizes proteins against global unfolding [51]. Due to bound FMN, the stability against global unfolding of flavodoxin is much higher than that of apoflavodoxin. As a result, global unfolding of flavodoxin is a rare event, occurring approximately once every 3 hours [33]. The stability of flavodoxin is so high that FMN needs to be released first before global unfolding of the protein can occur [33]. Hydrogen/deuterium exchange studies revealed that FMN binding protects the majority of flavodoxin's residues against local protein unfolding [44], [52], [53]. In contrast to apoflavodoxin, the backbone amide protons of several residues in the flavin-binding region of flavodoxin exchange extremely slowly with deuterons of deuterium oxide [44], [52]. This slow exchange reflects the rigidity of the flavin-binding region in flavodoxin, which is caused by the many interactions that exist between FMN and apoprotein. These observations highlight that a secondary role flavin binding has is protecting flavoproteins against unfolding.
The study presented here highlights another secondary role of flavin binding: i.e., the importance of the FMN cofactor in protecting flavodoxin against irreversible oxidative damage. The data show that apoflavodoxin is much more susceptible to H2O2-induced oxidative stress than holoprotein. This is likely caused by an increased accessibility of Cys69. Furthermore, dissociation of FMN potentially affects the pKa of this residue. Both apo- and holoprotein first reversibly oxidise to their sulfenic acid states (Figure 1). Subsequently, in case of apoflavodoxin, sulfenic acid is irreversibly oxidised to sulfinic and sulfonic acid states. In addition, part of the sulfenic acid population reacts with unmodified apoflavodoxin monomers, thereby generating disulfide-linked protein dimers. In contrast, in case of flavodoxin, oxidation beyond the sulfenic acid state is not detected. Flavodoxin does not dimerize and is also considerably less susceptible to covalent modification by TNB and NBD-Cl than apoflavodoxin. Apparently, upon sulfenylation, the side chain of Cys69 becomes even further stabilized and protected against subsequent modification.
In conclusion, besides its primary role as redox-active moiety, binding of FMN leads to considerably improved stability of flavodoxin against unfolding and to strong protection against oxidative stress.
Materials and Methods
Chemicals
FMN and 1,4-dithiothreitol (DTT) were from Sigma-Aldrich. Ammonium acetate and 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) were from Merck, and H2O2 (30% w/v) was from Fisher. NBD-Cl from Acros Organics was dissolved in dimethyl sulfoxide.
Protein purification and preparation of apoprotein
Wild-type flavodoxin II from A. vinelandii strain ATCC 478 was expressed in E. coli TG2 (pAV34) and purified as described [54], with omission of DTT. The purified protein migrated as one homogeneous band in SDS-polyacrylamide gel electrophoresis. Holoprotein gave rise to an A276/A450 absorbance ratio of 5.4. C69A flavodoxin was prepared as described [54]. To produce apoflavodoxin, FMN was removed from flavodoxin by trichloroacetic acid (TCA) precipitation [54]. Before dissolving in 300 mM Tris-HCl pH 8.5, protein pellet was washed twice with 3% (w/v) TCA containing 1 mM DTT [31]. To avoid disulfide bond formation between apoprotein monomers, apoflavodoxin was stored in the presence of 10 mM DTT. Prior to experiments, by using Biogel-P6DG gel filtration (BioRad), flavodoxin as well as apoflavodoxin were brought into 50 mM ammonium acetate, 0.1 mM EDTA, pH 6.8. All experiments with holo- and apoprotein were performed using this buffer.
Protein modification
Reactions of flavodoxin (41 μM) and apoflavodoxin (31 μM) with DTNB were carried out at 20°C according to the method of Ellman [55] with the modifications of Habeeb [56]. DTNB concentration was 200 μM. Time-dependent release of 2-nitro-5-thio-benzoate anion (TNB) was measured at 412 nm (ε412(TNB) = 13.6 mM−1cm−1). Apoflavodoxin (20 μM) was also treated for 1 h at 20°C with 200 μM NBD-Cl (stock contained 100 mM NBD-Cl in dimethyl sulfoxide). In another experiment, apoflavodoxin was first oxidised at room temperature with 10 mM H2O2 for periods of 10 and 90 min, respectively, and subsequently incubated with NBD-Cl, as described. In addition, DTT-pre-treated flavodoxin (28 μM) was incubated for 100 min at 20°C with 190 μM NBD-Cl.
Fast protein liquid chromatography
Size-exclusion chromatography was performed using a Superdex 75 HR 10/30 column. Anion exchange chromatography was done using a MonoQ HR5/5 column. All FPLC separations were performed at room temperature using an ÄKTA Explorer (GE healthcare).
Spectral analysis
Absorption spectra were recorded at 25°C on a Hewlett Packard 8453 diode array spectrophotometer. Flavodoxin's molar absorption coefficient of 10.8 mM−1cm−1 at 450 nm was determined by recording absorption spectra of protein in presence and absence of 0.1% (w/v) SDS, using a molar absorption coefficient for free FMN of 12.2 mM−1cm−1 at 445 nm.
Nano-electrospray mass spectrometry
Native MS spectra of protein were obtained by using an LC-T nano-electrospray ionization orthogonal time-of-flight mass spectrometer (Micromass, Manchester, UK), operating in positive ion mode. Spraying conditions were: needle voltage 1250–1450 V, cone voltage 50–125 V and source temperature 80°C. To prepare nano-electrospray needles, borosilicate glass capillaries (Kwik-FilTM, World Precision Instruments Inc., Sarasota, FL) and a P-97 puller (Sutter Instrument Co., Novato, CA) were used. The resulting needles were subsequently coated with a thin gold layer (∼500 Å) by using an Edwards Scancoat six Pirani 501 sputter coater (Edwards High Vacuum International, Crawley, UK).
Liquid chromatography-mass spectrometry (LC-MS)
For liquid chromatography use was made of a LC-10AD Shimadzu two pump system coupled to a SPD-10A UV-VIS Shimadzu detector, which was set to 210 nm. Protein samples were brought onto a Vydac 218TP54 C18-reversed phase analytical column (250×4.6 mm internal diameter, 5 µm particle size) and a Vydac 218TP5115 C18-reversed phase microbore column (150×1 mm internal diameter, 5 µm particle size), which was protected by an Optimize technologies OPTI-GUARD C18-reversed phase 1 mm guard column. Flow rate of the mobile phase through the analytical Vydac column was 0.6 mL/min. Flow rate through the microbore column was 0.05 mL/min. The mobile phase was a mixture of solvent A (milli-Q water containing 0.05% (v/v) trifluoroacetic acid (TFA)) and solvent B (95% (v/v) acetonitrile, containing 0.05 (v/v) TFA). This mixture initially contained 40% solvent B for a period of 5 min. Subsequently, in a time span of 10 min, concentration of solvent B was increased to 60% and kept isocratically for 5 min. After this time period, solvent mixture was brought back in 5 min to initial composition (i.e., 40% B). The LC-T mass spectrometer of the LC-MS set-up operated in positive ion mode with 3 kV capillary voltage, 50 V cone voltage, 120°C source temperature and 250 L/h desolvation gas flow.
Acknowledgments
We thank Nora Tahallah and Kees Versluis for help with mass spectrometry experiments. The Netherlands Organisation for Scientific Research (NWO) supported SL.
Author Contributions
Conceived and designed the experiments: CPMVM WJHVB. Performed the experiments: SL WAMVDB RHHVDH. Analyzed the data: SL WAMVDB RHHVDH AJRH CPMVM WJHVB. Contributed reagents/materials/analysis tools: AJRH CPMVM WJHVB. Wrote the paper: SL CPMVM WJHVB.
Citation: Lindhoud S, van den Berg WAM, van den Heuvel RHH, Heck AJR, van Mierlo CPM, van Berkel WJH (2012) Cofactor Binding Protects Flavodoxin against Oxidative Stress. PLoS ONE 7(7): e41363. https://doi.org/10.1371/journal.pone.0041363
1. Ames BN, Shigenaga MK, Hagen TM (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 90: 7915–7922.BN AmesMK ShigenagaTM Hagen1993Oxidants, antioxidants, and the degenerative diseases of aging.Proc Natl Acad Sci U S A9079157922
2. Chao CC, Ma YS, Stadtman ER (1997) Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems. Proc Natl Acad Sci U S A 94: 2969–2974.CC ChaoYS MaER Stadtman1997Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems.Proc Natl Acad Sci U S A9429692974
3. Stadtman ER, Berlett BS (1998) Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev 30: 225–243.ER StadtmanBS Berlett1998Reactive oxygen-mediated protein oxidation in aging and disease.Drug Metab Rev30225243
4. Brandes N, Schmitt S, Jakob U (2009) Thiol-based redox switches in eukaryotic proteins. Antioxidants & redox signaling 11: 997–1014.N. BrandesS. SchmittU. Jakob2009Thiol-based redox switches in eukaryotic proteins.Antioxidants & redox signaling119971014
5. Wang Y, Yang J, Yi J (2011) Redox Sensing by Proteins: Oxidative Modifications on Cysteines and the Consequent Events. Antioxidants & redox signaling 16: 649–657.Y. WangJ. YangJ. Yi2011Redox Sensing by Proteins: Oxidative Modifications on Cysteines and the Consequent Events.Antioxidants & redox signaling16649657
6. Banerjee SK, Mudd JB (1992) Reaction of Ozone with Glycophorin in Solution and in Lipid Vesicles. Arch Biochem Biophys 295: 84–89.SK BanerjeeJB Mudd1992Reaction of Ozone with Glycophorin in Solution and in Lipid Vesicles.Arch Biochem Biophys2958489
7. Davis DA, Newcomb FM, Moskovitz J, Fales HM, Levine RL, et al. (2002) Reversible oxidation of HIV-2 protease. Methods Enzymol 348: 249–259.DA DavisFM NewcombJ. MoskovitzHM FalesRL Levine2002Reversible oxidation of HIV-2 protease.Methods Enzymol348249259
8. Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, et al. (2001) Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci U S A 98: 12920–12925.J. MoskovitzS. Bar-NoyWM WilliamsJ. RequenaBS Berlett2001Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals.Proc Natl Acad Sci U S A981292012925
9. Cabreiro F, Picot CR, Perichon M, Castel J, Friguet B, et al. (2008) Overexpression of mitochondrial methionine sulfoxide reductase B2 protects leukemia cells from oxidative stress-induced cell death and protein damage. J Biol Chem 283: 16673–16681.F. CabreiroCR PicotM. PerichonJ. CastelB. Friguet2008Overexpression of mitochondrial methionine sulfoxide reductase B2 protects leukemia cells from oxidative stress-induced cell death and protein damage.J Biol Chem2831667316681
10. Perez VI, Bokov A, Van Remmen H, Mele J, Ran Q, et al. (2009) Is the oxidative stress theory of aging dead? Biochim Biophys Acta 1790: 1005–1014.VI PerezA. BokovH. Van RemmenJ. MeleQ. Ran2009Is the oxidative stress theory of aging dead?Biochim Biophys Acta179010051014
11. De Luca A, Sanna F, Sallese M, Ruggiero C, Grossi M, et al. (2010) Methionine sulfoxide reductase A down-regulation in human breast cancer cells results in a more aggressive phenotype. Proc Natl Acad Sci U S A 107: 18628–18633.A. De LucaF. SannaM. SalleseC. RuggieroM. Grossi2010Methionine sulfoxide reductase A down-regulation in human breast cancer cells results in a more aggressive phenotype.Proc Natl Acad Sci U S A1071862818633
12. Weerapana E, Wang C, Simon GM, Richter F, Khare S, et al. (2010) Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 468: 790–795.E. WeerapanaC. WangGM SimonF. RichterS. Khare2010Quantitative reactivity profiling predicts functional cysteines in proteomes.Nature468790795
13. Little C, O'Brien PJ (1969) Mechanism of peroxide-inactivation of the sulphydryl enzyme glyceraldehyde-3-phosphate dehydrogenase. Eur J Biochem 10: 533–538.C. LittlePJ O'Brien1969Mechanism of peroxide-inactivation of the sulphydryl enzyme glyceraldehyde-3-phosphate dehydrogenase.Eur J Biochem10533538
14. Allison WS (1976) Formation and reactions of sulfenic acids in proteins. Acc Chem Res 9: 293–299.WS Allison1976Formation and reactions of sulfenic acids in proteins.Acc Chem Res9293299
15. Claiborne A, Miller H, Parsonage D, Ross RP (1993) Protein-sulfenic acid stabilization and function in enzyme catalysis and gene regulation. Faseb J 7: 1483–1490.A. ClaiborneH. MillerD. ParsonageRP Ross1993Protein-sulfenic acid stabilization and function in enzyme catalysis and gene regulation.Faseb J714831490
16. Claiborne A, Yeh JI, Mallett TC, Luba J, Crane EJ 3rd, et al (1999) Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry 38: 15407–15416.Claiborne A, Yeh JI, Mallett TC, Luba J, Crane EJ 3rd, et al1999Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation.Biochemistry381540715416
17. Saurin AT, Neubert H, Brennan JP, Eaton P (2004) Widespread sulfenic acid formation in tissues in response to hydrogen peroxide. Proc Natl Acad Sci U S A 101: 17982–17987.AT SaurinH. NeubertJP BrennanP. Eaton2004Widespread sulfenic acid formation in tissues in response to hydrogen peroxide.Proc Natl Acad Sci U S A1011798217987
18. Leonard SE, Carroll KS (2011) Chemical ‘omics’ approaches for understanding protein cysteine oxidation in biology. Curr Opin Chem Biol 15: 88–102.SE LeonardKS Carroll2011Chemical ‘omics’ approaches for understanding protein cysteine oxidation in biology.Curr Opin Chem Biol1588102
19. Chang YC, Huang CN, Lin CH, Chang HC, Wu CC (2010) Mapping protein cysteine sulfonic acid modifications with specific enrichment and mass spectrometry: an integrated approach to explore the cysteine oxidation. Proteomics 10: 2961–2971.YC ChangCN HuangCH LinHC ChangCC Wu2010Mapping protein cysteine sulfonic acid modifications with specific enrichment and mass spectrometry: an integrated approach to explore the cysteine oxidation.Proteomics1029612971
20. Chiappetta G, Ndiaye S, Igbaria A, Kumar C, Vinh J, et al. (2010) Proteome screens for Cys residues oxidation: the redoxome. Methods Enzymol 473: 199–216.G. ChiappettaS. NdiayeA. IgbariaC. KumarJ. Vinh2010Proteome screens for Cys residues oxidation: the redoxome.Methods Enzymol473199216
21. Jeong J, Jung Y, Na S, Jeong J, Lee E, et al. (2011) Novel oxidative modifications in redox-active cysteine residues. Mol Cell Proteomics 10: M110.0005131–00051313.J. JeongY. JungS. NaJ. JeongE. Lee2011Novel oxidative modifications in redox-active cysteine residues.Mol Cell Proteomics10M110.000513100051313
22. Van Berkel WJ, Müller F (1987) The elucidation of the microheterogeneity of highly purified p-hydroxybenzoate hydroxylase from Pseudomonas fluorescens by various biochemical techniques. Eur J Biochem 167: 35–46.WJ Van BerkelF. Müller1987The elucidation of the microheterogeneity of highly purified p-hydroxybenzoate hydroxylase from Pseudomonas fluorescens by various biochemical techniques.Eur J Biochem1673546
23. Hamann M, Zhang T, Hendrich S, Thomas JA (2002) Quantitation of protein sulfinic and sulfonic acid, irreversibly oxidized protein cysteine sites in cellular proteins. Methods Enzymol 348: 146–156.M. HamannT. ZhangS. HendrichJA Thomas2002Quantitation of protein sulfinic and sulfonic acid, irreversibly oxidized protein cysteine sites in cellular proteins.Methods Enzymol348146156
24. Hochgrafe F, Mostertz J, Albrecht D, Hecker M (2005) Fluorescence thiol modification assay: oxidatively modified proteins in Bacillus subtilis. Mol Microbiol 58: 409–425.F. HochgrafeJ. MostertzD. AlbrechtM. Hecker2005Fluorescence thiol modification assay: oxidatively modified proteins in Bacillus subtilis.Mol Microbiol58409425
25. Eschrich K, van Berkel WJ, Westphal AH, de Kok A, Mattevi A, et al. (1990) Engineering of microheterogeneity-resistant p-hydroxybenzoate hydroxylase from Pseudomonas fluorescens. FEBS Lett 277: 197–199.K. EschrichWJ van BerkelAH WestphalA. de KokA. Mattevi1990Engineering of microheterogeneity-resistant p-hydroxybenzoate hydroxylase from Pseudomonas fluorescens.FEBS Lett277197199
26. Slavica A, Dib I, Nidetzky B (2005) Single-site oxidation, cysteine 108 to cysteine sulfinic acid, in D-amino acid oxidase from Trigonopsis variabilis and its structural and functional consequences. Appl Environ Microbiol 71: 8061–8068.A. SlavicaI. DibB. Nidetzky2005Single-site oxidation, cysteine 108 to cysteine sulfinic acid, in D-amino acid oxidase from Trigonopsis variabilis and its structural and functional consequences.Appl Environ Microbiol7180618068
27. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, et al. (2003) Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300: 653–656.HA WooHZ ChaeSC HwangKS YangSW Kang2003Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation.Science300653656
28. Fu X, Kassim SY, Parks WC, Heinecke JW (2001) Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 276: 41279–41287.X. FuSY KassimWC ParksJW Heinecke2001Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase.J Biol Chem2764127941287
29. Benemann JR, Yoch DC, Valentine RC, Arnon DI (1969) The electron transport system in nitrogen fixation by Azotobacter. I. Azotoflavin as an electron carrier. Proc Natl Acad Sci U S A 64: 1079–1086.JR BenemannDC YochRC ValentineDI Arnon1969The electron transport system in nitrogen fixation by Azotobacter. I. Azotoflavin as an electron carrier.Proc Natl Acad Sci U S A6410791086
30. Alagaratnam S, van Pouderoyen G, Pijning T, Dijkstra BW, Cavazzini D, et al. (2005) A crystallographic study of Cys69Ala flavodoxin II from Azotobacter vinelandii: structural determinants of redox potential. Protein Sci 14: 2284–2295.S. AlagaratnamG. van PouderoyenT. PijningBW DijkstraD. Cavazzini2005A crystallographic study of Cys69Ala flavodoxin II from Azotobacter vinelandii: structural determinants of redox potential.Protein Sci1422842295
31. Bollen YJ, Sanchéz IE, van Mierlo CP (2004) Formation of on- and off-pathway intermediates in the folding kinetics of Azotobacter vinelandii apoflavodoxin. Biochemistry 43: 10475–10489.YJ BollenIE SanchézCP van Mierlo2004Formation of on- and off-pathway intermediates in the folding kinetics of Azotobacter vinelandii apoflavodoxin.Biochemistry431047510489
32. Bollen YJ, van Mierlo CP (2005) Protein topology affects the appearance of intermediates during the folding of proteins with a flavodoxin-like fold. Biophys Chem 114: 181–189.YJ BollenCP van Mierlo2005Protein topology affects the appearance of intermediates during the folding of proteins with a flavodoxin-like fold.Biophys Chem114181189
33. Bollen YJ, Nabuurs SM, van Berkel WJ, van Mierlo CP (2005) Last in, first out: The role of cofactor binding in flavodoxin folding. J Biol Chem 280: 7836–7844.YJ BollenSM NabuursWJ van BerkelCP van Mierlo2005Last in, first out: The role of cofactor binding in flavodoxin folding.J Biol Chem28078367844
34. Bollen YJ, Kamphuis MB, van Mierlo CP (2006) The folding energy landscape of apoflavodoxin is rugged: Hydrogen exchange reveals nonproductive misfolded intermediates. Proc Natl Acad Sci U S A 103: 4095–4100.YJ BollenMB KamphuisCP van Mierlo2006The folding energy landscape of apoflavodoxin is rugged: Hydrogen exchange reveals nonproductive misfolded intermediates.Proc Natl Acad Sci U S A10340954100
35. Nabuurs SM, Westphal AH, van Mierlo CP (2008) Extensive formation of off-pathway species during folding of an alpha-beta parallel protein is due to docking of (non)native structure elements in unfolded molecules. J Am Chem Soc 130: 16914–16920.SM NabuursAH WestphalCP van Mierlo2008Extensive formation of off-pathway species during folding of an alpha-beta parallel protein is due to docking of (non)native structure elements in unfolded molecules.J Am Chem Soc1301691416920
36. Engel R, Westphal AH, Huberts DH, Nabuurs SM, Lindhoud S, et al. (2008) Macromolecular crowding compacts unfolded apoflavodoxin and causes severe aggregation of the off-pathway intermediate during apoflavodoxin folding. J Biol Chem 283: 27383–27394.R. EngelAH WestphalDH HubertsSM NabuursS. Lindhoud2008Macromolecular crowding compacts unfolded apoflavodoxin and causes severe aggregation of the off-pathway intermediate during apoflavodoxin folding.J Biol Chem2832738327394
37. Nabuurs SM, Westphal AH, van Mierlo CP (2009) Non-cooperative formation of the off-pathway molten globule during folding of the α-β parallel protein apoflavodoxin. J Am Chem Soc 131: 2739–2746.SM NabuursAH WestphalCP van Mierlo2009Non-cooperative formation of the off-pathway molten globule during folding of the α-β parallel protein apoflavodoxin.J Am Chem Soc13127392746
38. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, et al. (2012) The Pfam protein families database. Nucleic Acids Res 40: D290–D301.M. PuntaPC CoggillRY EberhardtJ. MistryJ. Tate2012The Pfam protein families database.Nucleic Acids Res40D290D301
39. Peelen S, Wijmenga S, Erbel PJ, Robson RL, Eady RR, et al. (1996) Possible role of a short extra loop of the long-chain flavodoxin from Azotobacter chroococcum in electron transfer to nitrogenase: complete 1H, 15N and 13C backbone assignments and secondary solution structure of the flavodoxin. J Biomol NMR 7: 315–330.S. PeelenS. WijmengaPJ ErbelRL RobsonRR Eady1996Possible role of a short extra loop of the long-chain flavodoxin from Azotobacter chroococcum in electron transfer to nitrogenase: complete 1H, 15N and 13C backbone assignments and secondary solution structure of the flavodoxin.J Biomol NMR7315330
40. Yoch DC (1975) Dimerization of Azotobacter vinelandii flavodoxin (azotoflavin). Arch Biochem Biophys 170: 326–333.DC Yoch1975Dimerization of Azotobacter vinelandii flavodoxin (azotoflavin).Arch Biochem Biophys170326333
41. Tanaka M, Haniu M, Yasunobu KT, Yoch DC (1977) Complete amino acid sequence of azotoflavin, a flavodoxin from Azotobacter vinelandii. Biochemistry 16: 3525–3537.M. TanakaM. HaniuKT YasunobuDC Yoch1977Complete amino acid sequence of azotoflavin, a flavodoxin from Azotobacter vinelandii.Biochemistry1635253537
42. Steensma E, Heering HA, Hagen WR, Van Mierlo CP (1996) Redox properties of wild-type, Cys69Ala, and Cys69Ser Azotobacter vinelandii flavodoxin II as measured by cyclic voltammetry and EPR spectroscopy. Eur J Biochem 235: 167–172.E. SteensmaHA HeeringWR HagenCP Van Mierlo1996Redox properties of wild-type, Cys69Ala, and Cys69Ser Azotobacter vinelandii flavodoxin II as measured by cyclic voltammetry and EPR spectroscopy.Eur J Biochem235167172
43. Wolfova J, Smatanova IK, Brynda J, Mesters JR, Lapkouski M, et al. (2009) Structural organization of WrbA in apo- and holoprotein crystals. Biochim Biophys Acta 1794: 1288–1298.J. WolfovaIK SmatanovaJ. BryndaJR MestersM. Lapkouski2009Structural organization of WrbA in apo- and holoprotein crystals.Biochim Biophys Acta179412881298
44. Steensma E, van Mierlo CP (1998) Structural characterisation of apoflavodoxin shows that the location of the stable nucleus differs among proteins with a flavodoxin-like topology. J Mol Biol 282: 653–666.E. SteensmaCP van Mierlo1998Structural characterisation of apoflavodoxin shows that the location of the stable nucleus differs among proteins with a flavodoxin-like topology.J Mol Biol282653666
45. Leferink NG, van Duijn E, Barendregt A, Heck AJ, van Berkel WJ (2009) Galactonolactone dehydrogenase requires a redox-sensitive thiol for optimal production of vitamin C. Plant Physiol 150: 596–605.NG LeferinkE. van DuijnA. BarendregtAJ HeckWJ van Berkel2009Galactonolactone dehydrogenase requires a redox-sensitive thiol for optimal production of vitamin C. Plant Physiol150596605
46. Poole LB, Ellis HR (2002) Identification of cysteine sulfenic acid in AhpC of alkyl hydroperoxide reductase. Methods Enzymol 348: 122–136.LB PooleHR Ellis2002Identification of cysteine sulfenic acid in AhpC of alkyl hydroperoxide reductase.Methods Enzymol348122136
47. Ellis HR, Poole LB (1997) Novel application of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole to identify cysteine sulfenic acid in the AhpC component of alkyl hydroperoxide reductase. Biochemistry 36: 15013–15018.HR EllisLB Poole1997Novel application of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole to identify cysteine sulfenic acid in the AhpC component of alkyl hydroperoxide reductase.Biochemistry361501315018
48. Heck AJR (2008) Native mass spectrometry: a bridge between interactomics and structural biology. Nat Methods 5: 927–933.AJR Heck2008Native mass spectrometry: a bridge between interactomics and structural biology.Nat Methods5927933
49. Denu JM, Tanner KG (1998) Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37: 5633–5642.JM DenuKG Tanner1998Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation.Biochemistry3756335642
50. Hefti MH, Vervoort J, van Berkel WJ (2003) Deflavination and reconstitution of flavoproteins. Eur J Biochem 270: 4227–4242.MH HeftiJ. VervoortWJ van Berkel2003Deflavination and reconstitution of flavoproteins.Eur J Biochem27042274242
51. Creighton TE (1993) Proteins, stuctures and molecular properties. New York: W. H. Freeman and Company. TE Creighton1993Proteins, stuctures and molecular properties.New York: W. H. Freeman and Company
52. Steensma E, Nijman MJ, Bollen YJ, de Jager PA, van den Berg WA, et al. (1998) Apparent local stability of the secondary structure of Azotobacter vinelandii holoflavodoxin II as probed by hydrogen exchange: implications for redox potential regulation and flavodoxin folding. Protein Sci 7: 306–317.E. SteensmaMJ NijmanYJ BollenPA de JagerWA van den Berg1998Apparent local stability of the secondary structure of Azotobacter vinelandii holoflavodoxin II as probed by hydrogen exchange: implications for redox potential regulation and flavodoxin folding.Protein Sci7306317
53. van Mierlo CP, Steensma E (2000) Protein folding and stability investigated by fluorescence, circular dichroism (CD), and nuclear magnetic resonance (NMR) spectroscopy: the flavodoxin story. J Biotechnol 79: 281–298.CP van MierloE. Steensma2000Protein folding and stability investigated by fluorescence, circular dichroism (CD), and nuclear magnetic resonance (NMR) spectroscopy: the flavodoxin story.J Biotechnol79281298
54. van Mierlo CP, van Dongen WM, Vergeldt F, van Berkel WJ, Steensma E (1998) The equilibrium unfolding of Azotobacter vinelandii apoflavodoxin II occurs via a relatively stable folding intermediate. Protein Sci 7: 2331–2344.CP van MierloWM van DongenF. VergeldtWJ van BerkelE. Steensma1998The equilibrium unfolding of Azotobacter vinelandii apoflavodoxin II occurs via a relatively stable folding intermediate.Protein Sci723312344
55. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70–77.GL Ellman1959Tissue sulfhydryl groups.Arch Biochem Biophys827077
56. Habeeb AFSA (1972) Reaction of protein sulfhydryl groups with Ellman's reagent. Methods Enzymol 25: 457–464.AFSA Habeeb1972Reaction of protein sulfhydryl groups with Ellman's reagent.Methods Enzymol25457464
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2012 Lindhoud et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
In organisms, various protective mechanisms against oxidative damaging of proteins exist. Here, we show that cofactor binding is among these mechanisms, because flavin mononucleotide (FMN) protects Azotobacter vinelandii flavodoxin against hydrogen peroxide-induced oxidation. We identify an oxidation sensitive cysteine residue in a functionally important loop close to the cofactor, i.e., Cys69. Oxidative stress causes dimerization of apoflavodoxin (i.e., flavodoxin without cofactor), and leads to consecutive formation of sulfinate and sulfonate states of Cys69. Use of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) reveals that Cys69 modification to a sulfenic acid is a transient intermediate during oxidation. Dithiothreitol converts sulfenic acid and disulfide into thiols, whereas the sulfinate and sulfonate forms of Cys69 are irreversible with respect to this reagent. A variable fraction of Cys69 in freshly isolated flavodoxin is in the sulfenic acid state, but neither oxidation to sulfinic and sulfonic acid nor formation of intermolecular disulfides is observed under oxidising conditions. Furthermore, flavodoxin does not react appreciably with NBD-Cl. Besides its primary role as redox-active moiety, binding of flavin leads to considerably improved stability against protein unfolding and to strong protection against irreversible oxidation and other covalent thiol modifications. Thus, cofactors can protect proteins against oxidation and modification.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer